Forma therapeutics investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of forma therapeutics, holdings inc. - fmtx

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of forma therapeutics, holdings inc. (nasdaqgm: fmtx) to novo nordisk a/s (nyse: nvo). under the terms of the proposed transaction, shareholders of forma will receive $20 in cash for each share of forma that they own. ksf is seeking to determine whether this consideration and the process that led to it are adequa
NVO Ratings Summary
NVO Quant Ranking